nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Ifosfamide—testicular cancer	0.312	0.682	CbGbCtD
Letrozole—CYP3A4—Ifosfamide—testicular cancer	0.0625	0.136	CbGbCtD
Letrozole—CYP19A1—corpus luteum—testicular cancer	0.0615	0.376	CbGeAlD
Letrozole—CYP19A1—seminiferous tubule of testis—testicular cancer	0.0521	0.318	CbGeAlD
Letrozole—CYP3A4—Vinblastine—testicular cancer	0.0331	0.0723	CbGbCtD
Letrozole—CYP3A4—Etoposide—testicular cancer	0.0299	0.0652	CbGbCtD
Letrozole—CYP19A1—semen—testicular cancer	0.0288	0.176	CbGeAlD
Letrozole—CYP3A4—Doxorubicin—testicular cancer	0.0204	0.0444	CbGbCtD
Letrozole—CYP2A6—seminal vesicle—testicular cancer	0.00779	0.0476	CbGeAlD
Letrozole—CYP19A1—gonad—testicular cancer	0.00441	0.027	CbGeAlD
Letrozole—CYP19A1—female gonad—testicular cancer	0.00359	0.0219	CbGeAlD
Letrozole—CYP19A1—testis—testicular cancer	0.00318	0.0194	CbGeAlD
Letrozole—CYP19A1—lymph node—testicular cancer	0.00231	0.0141	CbGeAlD
Letrozole—Weight decreased—Epirubicin—testicular cancer	0.000328	0.000867	CcSEcCtD
Letrozole—Dyspnoea—Etoposide—testicular cancer	0.000328	0.000867	CcSEcCtD
Letrozole—Somnolence—Etoposide—testicular cancer	0.000327	0.000865	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—testicular cancer	0.000327	0.000864	CcSEcCtD
Letrozole—Hepatobiliary disease—Methotrexate—testicular cancer	0.000327	0.000864	CcSEcCtD
Letrozole—Nausea—Bleomycin—testicular cancer	0.000324	0.000856	CcSEcCtD
Letrozole—Infestation NOS—Epirubicin—testicular cancer	0.000323	0.000855	CcSEcCtD
Letrozole—Infestation—Epirubicin—testicular cancer	0.000323	0.000855	CcSEcCtD
Letrozole—Vomiting—Dactinomycin—testicular cancer	0.000323	0.000855	CcSEcCtD
Letrozole—Rash—Dactinomycin—testicular cancer	0.00032	0.000847	CcSEcCtD
Letrozole—Decreased appetite—Etoposide—testicular cancer	0.00032	0.000846	CcSEcCtD
Letrozole—Diarrhoea—Ifosfamide—testicular cancer	0.000319	0.000843	CcSEcCtD
Letrozole—Gastrointestinal disorder—Etoposide—testicular cancer	0.000317	0.00084	CcSEcCtD
Letrozole—Body temperature increased—Cisplatin—testicular cancer	0.000317	0.000839	CcSEcCtD
Letrozole—Fatigue—Etoposide—testicular cancer	0.000317	0.000839	CcSEcCtD
Letrozole—Stomatitis—Epirubicin—testicular cancer	0.000315	0.000833	CcSEcCtD
Letrozole—Pain—Etoposide—testicular cancer	0.000314	0.000832	CcSEcCtD
Letrozole—Constipation—Etoposide—testicular cancer	0.000314	0.000832	CcSEcCtD
Letrozole—Urinary tract infection—Epirubicin—testicular cancer	0.000314	0.000831	CcSEcCtD
Letrozole—Haemoglobin—Methotrexate—testicular cancer	0.000312	0.000824	CcSEcCtD
Letrozole—Hepatitis—Methotrexate—testicular cancer	0.00031	0.00082	CcSEcCtD
Letrozole—Haemorrhage—Methotrexate—testicular cancer	0.00031	0.00082	CcSEcCtD
Letrozole—Sweating—Epirubicin—testicular cancer	0.00031	0.00082	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—testicular cancer	0.00031	0.00082	CcSEcCtD
Letrozole—Dizziness—Ifosfamide—testicular cancer	0.000308	0.000814	CcSEcCtD
Letrozole—Urinary tract disorder—Methotrexate—testicular cancer	0.000306	0.00081	CcSEcCtD
Letrozole—Hepatobiliary disease—Epirubicin—testicular cancer	0.000306	0.000809	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—testicular cancer	0.000305	0.000807	CcSEcCtD
Letrozole—Urethral disorder—Methotrexate—testicular cancer	0.000304	0.000804	CcSEcCtD
Letrozole—Weight decreased—Doxorubicin—testicular cancer	0.000303	0.000803	CcSEcCtD
Letrozole—Feeling abnormal—Etoposide—testicular cancer	0.000303	0.000802	CcSEcCtD
Letrozole—Nausea—Dactinomycin—testicular cancer	0.000302	0.000798	CcSEcCtD
Letrozole—Gastrointestinal pain—Etoposide—testicular cancer	0.000301	0.000795	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—testicular cancer	0.000299	0.000791	CcSEcCtD
Letrozole—Infestation—Doxorubicin—testicular cancer	0.000299	0.000791	CcSEcCtD
Letrozole—Vomiting—Ifosfamide—testicular cancer	0.000296	0.000783	CcSEcCtD
Letrozole—Rash—Ifosfamide—testicular cancer	0.000294	0.000777	CcSEcCtD
Letrozole—Dermatitis—Ifosfamide—testicular cancer	0.000293	0.000776	CcSEcCtD
Letrozole—Erythema multiforme—Methotrexate—testicular cancer	0.000293	0.000775	CcSEcCtD
Letrozole—Urticaria—Etoposide—testicular cancer	0.000292	0.000773	CcSEcCtD
Letrozole—Haemoglobin—Epirubicin—testicular cancer	0.000292	0.000771	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—testicular cancer	0.000291	0.000771	CcSEcCtD
Letrozole—Abdominal pain—Etoposide—testicular cancer	0.000291	0.000769	CcSEcCtD
Letrozole—Body temperature increased—Etoposide—testicular cancer	0.000291	0.000769	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—testicular cancer	0.000291	0.000769	CcSEcCtD
Letrozole—Haemorrhage—Epirubicin—testicular cancer	0.00029	0.000767	CcSEcCtD
Letrozole—Hepatitis—Epirubicin—testicular cancer	0.00029	0.000767	CcSEcCtD
Letrozole—Eye disorder—Methotrexate—testicular cancer	0.00029	0.000766	CcSEcCtD
Letrozole—Hypoaesthesia—Epirubicin—testicular cancer	0.000289	0.000764	CcSEcCtD
Letrozole—Asthenia—Cisplatin—testicular cancer	0.000288	0.000762	CcSEcCtD
Letrozole—Cardiac disorder—Methotrexate—testicular cancer	0.000288	0.000761	CcSEcCtD
Letrozole—Sweating—Doxorubicin—testicular cancer	0.000287	0.000758	CcSEcCtD
Letrozole—Urinary tract disorder—Epirubicin—testicular cancer	0.000287	0.000758	CcSEcCtD
Letrozole—Oedema peripheral—Epirubicin—testicular cancer	0.000286	0.000756	CcSEcCtD
Letrozole—Connective tissue disorder—Epirubicin—testicular cancer	0.000285	0.000754	CcSEcCtD
Letrozole—Urethral disorder—Epirubicin—testicular cancer	0.000284	0.000752	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000283	0.000748	CcSEcCtD
Letrozole—Angiopathy—Methotrexate—testicular cancer	0.000281	0.000744	CcSEcCtD
Letrozole—Mediastinal disorder—Methotrexate—testicular cancer	0.000279	0.000739	CcSEcCtD
Letrozole—Nausea—Ifosfamide—testicular cancer	0.000277	0.000732	CcSEcCtD
Letrozole—Diarrhoea—Cisplatin—testicular cancer	0.000275	0.000726	CcSEcCtD
Letrozole—Erythema multiforme—Epirubicin—testicular cancer	0.000274	0.000726	CcSEcCtD
Letrozole—Alopecia—Methotrexate—testicular cancer	0.000274	0.000725	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—testicular cancer	0.000272	0.000718	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—testicular cancer	0.000271	0.000717	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—testicular cancer	0.00027	0.000714	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—testicular cancer	0.00027	0.000714	CcSEcCtD
Letrozole—Flushing—Epirubicin—testicular cancer	0.000269	0.000712	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—testicular cancer	0.000269	0.000712	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—testicular cancer	0.000268	0.00071	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—testicular cancer	0.000268	0.00071	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000267	0.000707	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000265	0.000701	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—testicular cancer	0.000264	0.0007	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—testicular cancer	0.000264	0.000699	CcSEcCtD
Letrozole—Asthenia—Etoposide—testicular cancer	0.000264	0.000698	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000264	0.000698	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—testicular cancer	0.000263	0.000696	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—testicular cancer	0.000263	0.000696	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—testicular cancer	0.000261	0.000692	CcSEcCtD
Letrozole—Back pain—Methotrexate—testicular cancer	0.000261	0.000691	CcSEcCtD
Letrozole—Pruritus—Etoposide—testicular cancer	0.00026	0.000688	CcSEcCtD
Letrozole—Alopecia—Epirubicin—testicular cancer	0.000256	0.000678	CcSEcCtD
Letrozole—Vomiting—Cisplatin—testicular cancer	0.000255	0.000675	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—testicular cancer	0.000254	0.000673	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—testicular cancer	0.000254	0.000672	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—testicular cancer	0.000254	0.000671	CcSEcCtD
Letrozole—Rash—Cisplatin—testicular cancer	0.000253	0.000669	CcSEcCtD
Letrozole—Dermatitis—Cisplatin—testicular cancer	0.000253	0.000669	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—testicular cancer	0.000253	0.000668	CcSEcCtD
Letrozole—Diarrhoea—Etoposide—testicular cancer	0.000252	0.000666	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—testicular cancer	0.000251	0.000664	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—testicular cancer	0.00025	0.000662	CcSEcCtD
Letrozole—Flushing—Doxorubicin—testicular cancer	0.000249	0.000659	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—testicular cancer	0.000249	0.000659	CcSEcCtD
Letrozole—Tension—Epirubicin—testicular cancer	0.000248	0.000656	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—testicular cancer	0.000247	0.000654	CcSEcCtD
Letrozole—Nervousness—Epirubicin—testicular cancer	0.000245	0.000649	CcSEcCtD
Letrozole—Back pain—Epirubicin—testicular cancer	0.000244	0.000646	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—testicular cancer	0.000244	0.000644	CcSEcCtD
Letrozole—Malaise—Methotrexate—testicular cancer	0.000243	0.000644	CcSEcCtD
Letrozole—Dizziness—Etoposide—testicular cancer	0.000243	0.000643	CcSEcCtD
Letrozole—Vertigo—Methotrexate—testicular cancer	0.000242	0.000641	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—testicular cancer	0.000242	0.00064	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—testicular cancer	0.000242	0.000639	CcSEcCtD
Letrozole—Nausea—Cisplatin—testicular cancer	0.000238	0.000631	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—testicular cancer	0.000238	0.00063	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—testicular cancer	0.000237	0.000628	CcSEcCtD
Letrozole—Cough—Methotrexate—testicular cancer	0.000236	0.000623	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—testicular cancer	0.000235	0.000622	CcSEcCtD
Letrozole—Ill-defined disorder—Epirubicin—testicular cancer	0.000234	0.00062	CcSEcCtD
Letrozole—Vomiting—Etoposide—testicular cancer	0.000234	0.000618	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—testicular cancer	0.000234	0.000618	CcSEcCtD
Letrozole—Rash—Etoposide—testicular cancer	0.000232	0.000613	CcSEcCtD
Letrozole—Dermatitis—Etoposide—testicular cancer	0.000232	0.000613	CcSEcCtD
Letrozole—Headache—Etoposide—testicular cancer	0.00023	0.000609	CcSEcCtD
Letrozole—Chest pain—Methotrexate—testicular cancer	0.00023	0.000608	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—testicular cancer	0.00023	0.000608	CcSEcCtD
Letrozole—Myalgia—Methotrexate—testicular cancer	0.00023	0.000608	CcSEcCtD
Letrozole—Tension—Doxorubicin—testicular cancer	0.000229	0.000607	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—testicular cancer	0.000229	0.000605	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000228	0.000604	CcSEcCtD
Letrozole—Malaise—Epirubicin—testicular cancer	0.000228	0.000602	CcSEcCtD
Letrozole—Discomfort—Methotrexate—testicular cancer	0.000227	0.000601	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—testicular cancer	0.000227	0.0006	CcSEcCtD
Letrozole—Vertigo—Epirubicin—testicular cancer	0.000227	0.0006	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—testicular cancer	0.000226	0.000598	CcSEcCtD
Letrozole—Back pain—Doxorubicin—testicular cancer	0.000226	0.000598	CcSEcCtD
Letrozole—Palpitations—Epirubicin—testicular cancer	0.000223	0.00059	CcSEcCtD
Letrozole—Cough—Epirubicin—testicular cancer	0.00022	0.000583	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—testicular cancer	0.00022	0.000583	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—testicular cancer	0.00022	0.000583	CcSEcCtD
Letrozole—Infection—Methotrexate—testicular cancer	0.000219	0.000579	CcSEcCtD
Letrozole—Nausea—Etoposide—testicular cancer	0.000218	0.000578	CcSEcCtD
Letrozole—Hypertension—Epirubicin—testicular cancer	0.000218	0.000577	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000217	0.000574	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—testicular cancer	0.000216	0.000571	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—testicular cancer	0.000215	0.000569	CcSEcCtD
Letrozole—Myalgia—Epirubicin—testicular cancer	0.000215	0.000569	CcSEcCtD
Letrozole—Chest pain—Epirubicin—testicular cancer	0.000215	0.000569	CcSEcCtD
Letrozole—Anxiety—Epirubicin—testicular cancer	0.000214	0.000567	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—testicular cancer	0.000214	0.000566	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000214	0.000565	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—testicular cancer	0.000213	0.000563	CcSEcCtD
Letrozole—Discomfort—Epirubicin—testicular cancer	0.000212	0.000562	CcSEcCtD
Letrozole—Malaise—Doxorubicin—testicular cancer	0.000211	0.000557	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—testicular cancer	0.00021	0.000556	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—testicular cancer	0.00021	0.000555	CcSEcCtD
Letrozole—Anorexia—Methotrexate—testicular cancer	0.00021	0.000555	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—testicular cancer	0.000209	0.000553	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—testicular cancer	0.000207	0.000546	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—testicular cancer	0.000206	0.000545	CcSEcCtD
Letrozole—Oedema—Epirubicin—testicular cancer	0.000206	0.000545	CcSEcCtD
Letrozole—Infection—Epirubicin—testicular cancer	0.000205	0.000542	CcSEcCtD
Letrozole—Cough—Doxorubicin—testicular cancer	0.000204	0.000539	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—testicular cancer	0.000202	0.000535	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—testicular cancer	0.000202	0.000534	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—testicular cancer	0.000201	0.000532	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000201	0.000531	CcSEcCtD
Letrozole—Skin disorder—Epirubicin—testicular cancer	0.0002	0.00053	CcSEcCtD
Letrozole—Hyperhidrosis—Epirubicin—testicular cancer	0.000199	0.000527	CcSEcCtD
Letrozole—Insomnia—Methotrexate—testicular cancer	0.000199	0.000527	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—testicular cancer	0.000199	0.000526	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—testicular cancer	0.000199	0.000526	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—testicular cancer	0.000199	0.000526	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—testicular cancer	0.000198	0.000524	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—testicular cancer	0.000198	0.000523	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000198	0.000523	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—testicular cancer	0.000197	0.00052	CcSEcCtD
Letrozole—Anorexia—Epirubicin—testicular cancer	0.000196	0.00052	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—testicular cancer	0.000196	0.000519	CcSEcCtD
Letrozole—Somnolence—Methotrexate—testicular cancer	0.000196	0.000518	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—testicular cancer	0.000195	0.000515	CcSEcCtD
Letrozole—Dyspepsia—Methotrexate—testicular cancer	0.000194	0.000513	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—testicular cancer	0.000191	0.000506	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—testicular cancer	0.000191	0.000505	CcSEcCtD
Letrozole—Oedema—Doxorubicin—testicular cancer	0.000191	0.000505	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00019	0.000503	CcSEcCtD
Letrozole—Fatigue—Methotrexate—testicular cancer	0.00019	0.000502	CcSEcCtD
Letrozole—Infection—Doxorubicin—testicular cancer	0.000189	0.000501	CcSEcCtD
Letrozole—Pain—Methotrexate—testicular cancer	0.000188	0.000498	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000188	0.000497	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—testicular cancer	0.000187	0.000495	CcSEcCtD
Letrozole—Insomnia—Epirubicin—testicular cancer	0.000186	0.000493	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—testicular cancer	0.000186	0.000492	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—testicular cancer	0.000185	0.00049	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—testicular cancer	0.000185	0.00049	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—testicular cancer	0.000184	0.000488	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—testicular cancer	0.000184	0.000486	CcSEcCtD
Letrozole—Somnolence—Epirubicin—testicular cancer	0.000183	0.000485	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—testicular cancer	0.000182	0.000481	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—testicular cancer	0.000182	0.00048	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—testicular cancer	0.000181	0.00048	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—testicular cancer	0.00018	0.000476	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—testicular cancer	0.000179	0.000474	CcSEcCtD
Letrozole—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000178	0.000471	CcSEcCtD
Letrozole—Fatigue—Epirubicin—testicular cancer	0.000178	0.00047	CcSEcCtD
Letrozole—Pain—Epirubicin—testicular cancer	0.000176	0.000466	CcSEcCtD
Letrozole—Constipation—Epirubicin—testicular cancer	0.000176	0.000466	CcSEcCtD
Letrozole—Urticaria—Methotrexate—testicular cancer	0.000175	0.000463	CcSEcCtD
Letrozole—Abdominal pain—Methotrexate—testicular cancer	0.000174	0.000461	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—testicular cancer	0.000174	0.000461	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000174	0.00046	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—testicular cancer	0.000173	0.000456	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—testicular cancer	0.000171	0.000453	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—testicular cancer	0.00017	0.00045	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—testicular cancer	0.00017	0.000449	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—testicular cancer	0.00017	0.000449	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—testicular cancer	0.000169	0.000446	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—testicular cancer	0.000168	0.000444	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—testicular cancer	0.000166	0.000439	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000165	0.000436	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—testicular cancer	0.000164	0.000435	CcSEcCtD
Letrozole—Urticaria—Epirubicin—testicular cancer	0.000164	0.000433	CcSEcCtD
Letrozole—Pain—Doxorubicin—testicular cancer	0.000163	0.000431	CcSEcCtD
Letrozole—Constipation—Doxorubicin—testicular cancer	0.000163	0.000431	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—testicular cancer	0.000163	0.000431	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—testicular cancer	0.000163	0.000431	CcSEcCtD
Letrozole—Asthenia—Methotrexate—testicular cancer	0.000158	0.000418	CcSEcCtD
Letrozole—Feeling abnormal—Doxorubicin—testicular cancer	0.000157	0.000416	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000156	0.000413	CcSEcCtD
Letrozole—Pruritus—Methotrexate—testicular cancer	0.000156	0.000412	CcSEcCtD
Letrozole—Urticaria—Doxorubicin—testicular cancer	0.000152	0.000401	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—testicular cancer	0.000151	0.000399	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—testicular cancer	0.000151	0.000399	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—testicular cancer	0.000151	0.000399	CcSEcCtD
Letrozole—Asthenia—Epirubicin—testicular cancer	0.000148	0.000391	CcSEcCtD
Letrozole—Pruritus—Epirubicin—testicular cancer	0.000146	0.000386	CcSEcCtD
Letrozole—Dizziness—Methotrexate—testicular cancer	0.000146	0.000385	CcSEcCtD
Letrozole—Diarrhoea—Epirubicin—testicular cancer	0.000141	0.000373	CcSEcCtD
Letrozole—Vomiting—Methotrexate—testicular cancer	0.00014	0.00037	CcSEcCtD
Letrozole—Rash—Methotrexate—testicular cancer	0.000139	0.000367	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—testicular cancer	0.000139	0.000367	CcSEcCtD
Letrozole—Headache—Methotrexate—testicular cancer	0.000138	0.000365	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—testicular cancer	0.000137	0.000362	CcSEcCtD
Letrozole—Dizziness—Epirubicin—testicular cancer	0.000136	0.000361	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—testicular cancer	0.000135	0.000357	CcSEcCtD
Letrozole—Vomiting—Epirubicin—testicular cancer	0.000131	0.000347	CcSEcCtD
Letrozole—Nausea—Methotrexate—testicular cancer	0.000131	0.000346	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—testicular cancer	0.00013	0.000345	CcSEcCtD
Letrozole—Rash—Epirubicin—testicular cancer	0.00013	0.000344	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—testicular cancer	0.00013	0.000343	CcSEcCtD
Letrozole—Headache—Epirubicin—testicular cancer	0.000129	0.000342	CcSEcCtD
Letrozole—Dizziness—Doxorubicin—testicular cancer	0.000126	0.000334	CcSEcCtD
Letrozole—Nausea—Epirubicin—testicular cancer	0.000122	0.000324	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—testicular cancer	0.000121	0.000321	CcSEcCtD
Letrozole—Rash—Doxorubicin—testicular cancer	0.00012	0.000318	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—testicular cancer	0.00012	0.000318	CcSEcCtD
Letrozole—Headache—Doxorubicin—testicular cancer	0.000119	0.000316	CcSEcCtD
Letrozole—Nausea—Doxorubicin—testicular cancer	0.000113	0.0003	CcSEcCtD
